Category: Market News

Nov 01
Oil-price gains intensify on report of potential Iranian attack on Saudi Arabia

Oil futures climbed toward session highs on Tuesday after The Wall Street Journal reported that Saudi Arabia shared intelligence with the U.S. warning of a possible Iranian attack on targets in the kingdom. In response to the warning, Saudi Arabia, the U.S. and several other neighboring states raised alert levels for their military forces, the […]

Nov 01
Chief Justice Roberts delays release of Trump’s tax returns to House panel

Chief Justice John Roberts on Tuesday temporarily halted the release of former President Donald Trump’s tax returns to a House panel. Trump asked the Supreme Court on Monday to block the House Ways and Means Committee from accessing his tax records. Roberts called for more briefing in the case, reported the Washington Post, and called […]

Nov 01
JPMorgan Chase hires OrbiMed Advisors executive for new life sciences venture capital firm

JPMorgan Chase & Co. JPM, +1.26% said Tuesday its J.P. Morgan Asset Management unit is launching a new private capital team aimed at investments in life sciences. Stephen Squinto is now chief investment officer and managing partner of Life Sciences Private Capital for the bank. He previously worked at private equity firm OrbiMed Advisors. Squinto […]

Nov 01
Lilly’s new Type 2 diabetes drug had $187 million in sales in the third quarter

Eli Lilly & Co. Inc. LLY, +0.61% said its new Type 2 diabetes treatment Mounjaro brought in $187.3 million in sales in the third quarter of the year, beating the FactSet consensus of $79.0 million. It was the therapy’s first full quarter on the U.S. market after receiving approval from the Food and Drug Administration […]

Nov 01
Stryker Corp. stock falls after company lowers outlook for 2022

Shares of Stryker Corp. SYK, +0.00% fell more than 4% in the extended session Monday after the maker of surgical equipment and other medical devices reported third-quarter results above analyst expectations but lowered its profit outlook for the year, thanks to inflation and a stronger dollar. Striker earned $816 million, or $2.14 a share, in […]

Nov 01
Goodyear stock falls 11% after Q3 results disappoint on inflation, stronger dollar

Goodyear Tire & Rubber Co. GT, +1.44% shares fell 11% in the extended session Monday after the tire maker reported third-quarter earnings below Wall Street expectations and said “challenges” with inflation and a stronger dollar remain. Goodyear earned $44 million, or 16 cents a share, in the quarter, compared with $132 million, or 46 cents […]

Oct 31
Hologic stock jumps, as execs see ‘unprecedented strength’ entering new fiscal year

Shares of Hologic Inc. HOLX, +1.30% jumped 7.5% after hours on Monday after the maker of medical equipment and technology reported better-than-expected fiscal fourth-quarter results and issued some financial forecasts that were better than expected. The company, whose products focus on women’s health, said it was seeing “unprecedented strength” across its core businesses heading into […]

Oct 31
Avis Budget stock rallies 6% after company’s Q3 earnings top views

Shares of Avis Budget Group Inc. CAR, -2.83% rallied more than 6% in the extended session Monday after the car-rental company reported third-quarter earnings well above Wall Street expectations and said it expects the “strong” summer demand to carry through the end of the year. Avis earned $1.03 billion, or $21.67 a share, in the […]

Oct 31
Natural-gas futures gain nearly 12%, cutting their monthly loss; oil’s up 8.9% for the month

Natural-gas futures climbed by almost 12% on Monday, cutting their loss for the month, with volatility high as traders continued to keep an eye on U.S. supply levels for the winter heating season. December natural gas NGZ22, +11.22% rose 67 cents, or nearly 11.8%, to settle at $6.355 per million British thermal units on the […]

Oct 31
Actinium’s stock jumps 22% on new data for its acute myeloid leukemia therapy

Shares of Actinium Pharmaceuticals Inc. ATNM, +30.82% were up 22.8% in trading on Monday after the company met the primary endpoint in a Phase 3 clinical trial for its investigational treatment for relapsed or refractory acute myeloid leukemia. Actinium said it plans to share additional clinical data by the end of the year. The company’s […]